Xie T, Liu Q, Xie F, Liu H, Zhang Y
State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, P. R. China.
Prep Biochem Biotechnol. 2008;38(3):308-17. doi: 10.1080/10826060802165147.
In this work, Pichia pastoris was applied to produce human insulin by a simple procedure. The synthesized insulin precursor (ILP) gene was inserted into pPIC9K to obtain secretary expression plasmid pPIC9K/ILP. Pichia pastoris GS115 was transformed by pPIC9K/ILP and the high expresser was screened. In a 16 L fermentor, the insulin precursor production was 3.6 g/L. Insulin precursor, purified by one-step chromatography, was converted into human insulin by transpeptidation. The yield of the processing procedure from insulin precursor to insulin reached up to 70%. In vivo assay showed that the biological activity of the produced recombinant human insulin was 28.8 U/mg.
在本研究中,采用简单的方法利用毕赤酵母生产人胰岛素。将合成的胰岛素前体(ILP)基因插入pPIC9K中,获得分泌表达质粒pPIC9K/ILP。用pPIC9K/ILP转化毕赤酵母GS115,并筛选高表达菌株。在16 L发酵罐中,胰岛素前体产量为3.6 g/L。通过一步层析纯化的胰岛素前体经转肽作用转化为人胰岛素。从胰岛素前体到胰岛素的加工过程产率高达70%。体内试验表明,所生产的重组人胰岛素的生物活性为28.8 U/mg。